SCHEMBL9527397

SCHEMBL9527397

CC(C)(C)c1nc(C(=O)Cc2ccccc2)nn1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.37

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.35
AGTR1 P30556 6/20 0.35
AGTR2 P50052 6/20 0.35
GRN P28799 1/20 0.34
SORT1 Q99523 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9532338 0.91 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL6006875 0.91 AGTR1 (0.38) AGTR1AGTR2GRNSORT1
SCHEMBL9527539 0.89 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL9532573 0.88 AGTR1 (0.38) AGTR1AGTR2
SCHEMBL9528600 0.88 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9529471 0.86 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL6007916 0.85 PTGDR2 (0.37) PTGDR2AGTR1AGTR2
SCHEMBL9528717 0.85 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9530527 0.85 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9529383 0.84 AGTR1 (0.47) PTGDR2AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed